The Aspirin in Reducing Events in the Elderly (ASPREE) trial was a primary prevention trial that was established to investigate whether the daily use of 100 mg of enteric-coated aspirin would prolong the healthy life span of older adults. The trial, which was conducted in Australia and the United…
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly
